Results for tag: "Atrial Septal Defect Drug"

Atrial Septal Defect (ASD) is a type of congenital heart defect that affects the walls of the heart. It is one of the most common types of congenital heart defects, and is typically treated with drugs. Cardiovascular drugs are used to treat ASD, and include antiarrhythmic drugs, anticoagulants, and diuretics. Antiarrhythmic drugs are used to regulate the heart rate and rhythm, while anticoagulants are used to prevent blood clots. Diuretics are used to reduce fluid buildup in the lungs. The Atrial Septal Defect Drug market is a subset of the larger Cardiovascular Drugs market. It is a rapidly growing market, driven by the increasing prevalence of ASD and the need for effective treatments. The market is highly competitive, with a number of major players offering a range of products. Some of the leading companies in the Atrial Septal Defect Drug market include Pfizer, Merck, Sanofi, Novartis, and GlaxoSmithKline. Show Less Read more